Cystoid macular edema occurring after intracameral bimatoprost implantation

Abstract

Purpose

This case report aims to report the development of cystoid macular edema (CME) unilaterally following the administration of bimatoprost implant (Durysta) injections in both eyes for the treatment of primary open-angle glaucoma (POAG).

Observations

An 84-year-old female patient, previously diagnosed with POAG, underwent bimatoprost implant (Durysta) injections in both eyes, spaced one month apart. Subsequently, the patient experienced a gradual decline in visual acuity in her left eye attributed to the development of CME. The condition resolved following a treatment regimen involving topical dexamethasone and nepafenac.

Conclusion

The use of bimatoprost implant may lead to the occurrence of CME. Ophthalmologists must vigilantly monitor patients post-implantation, especially if they exhibit visual symptoms or have risk factors for a CME.

Keywords

open-angle glaucoma bimatoprost implant cystoid macular edema

Get full access to this article

View all access options for this article.

References

Zhou

Kansara

, et al. Intraocular pressure and eyedrop usage reduction with intracameral bimatoprost implant. J Ocul Pharmacol Ther 2023; 39: 398–403.

Weinreb

Christie

Medeiros

, et al. Single administration of bimatoprost implant: effects on 24-h intraocular pressure and 1-year outcomes. Ophthalmol Glaucoma 2023; 6: 599–608.

Bacharach

Tatham

Ferguson

, et al. Phase 3, randomized, 20-month study of the efficacy and safety of bimatoprost implant in patients with open-angle glaucoma and ocular hypertension (ARTEMIS 2). Drugs 2021; 81: 2017–2033.

Sirinek

Lin

. Intracameral sustained release bimatoprost implants (Durysta). Semin Ophthalmol 2022; 37: 385–390.

Yeh

Ramanathan

. Latanoprost and clinically significant cystoid macular edema after uneventful phacoemulsification with intraocular lens implantation. J Cataract Refract Surg 2002; 28: 1814–1818.

Warwar

Bullock

Ballal

. Cystoid macular edema and anterior uveitis associated with latanoprost use. Experience and incidence in a retrospective review of 94 patients. Ophthalmology 1998; 105: 263–268.

Weinreb

Bacharach

Brubaker

, et al. Bimatoprost implant biodegradation in the phase 3, randomized, 20-month ARTEMIS studies. J Ocul Pharmacol Ther 2023; 39: 55–62.

Patel

Badar

Bakhsh

, et al. Bilateral cystoid macular edema following bimatoprost implants. Retin Cases Brief Rep 2024; 8: 218–220.

Hollo

Aung

Cantor

, et al. Cystoid macular edema related to cataract surgery and topical prostaglandin analogs: mechanism, diagnosis, and management. Surv Ophthalmol 2020; 65: 496–512.

10.

Massa

Gobej

Jacquier

, et al. Cystoid macular oedema and iris-fixated intraocular lens treated with intraocular lens exchange: a case series and review. J Int Med Res 2019; 47: 188–195.

11.

Henderson

Kim

Ament

, et al. Clinical pseudophakic cystoid macular edema. Risk factors for development and duration after treatment. J Cataract Refract Surg 2007; 33: 1550–1558.

12.

Ozyol

Gunel-Karadeniz

. The use of prostaglandin analogues and cystoid macular edema after uneventful cataract surgery: a systematic review and meta-analysis. Semin Ophthalmol 2023; 38: 490–497.

13.

Hollo

. The side effects of the prostaglandin analogues. Expert Opin Drug Saf 2007; 6: 45–52.